Search Results - Davies, Robert JO, Prof

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Use of lipoteichoic acid-T for pleurodesis in malignant pleural effusion: a phase I toxicity and dose-escalation study

    Use of lipoteichoic acid-T for pleurodesis in malignant pleural effusion: a phase I toxicity and dose-escalation study by Rahman, Najib M, MRCP, Davies, Helen E, MRCP, Salzberg, Marc, Truog, Peter, MD, Midgely, Rachel, FRCP, Kerr, David, Prof, Clelland, Colin, FRCPath, Hedley, Emma L, Lee, YC Gary, PhD, Davies, Robert JO, Prof

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial

    Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial by Little, Paul, Prof, Stuart, Beth, PhD, Moore, Michael, FRCGP, Coenen, Samuel, Prof, Butler, Christopher C, Prof, Godycki-Cwirko, Maciek, Prof, Mierzecki, Artur, Prof, Chlabicz, Slawomir, PhD, Torres, Antoni, Prof, Almirall, Jordi, MD, Davies, Mel, MSc, Schaberg, Tom, PhD, Mölstad, Sigvard, Prof, Blasi, Francesco, Prof, De Sutter, An, PhD, Kersnik, Janko, Prof, Hupkova, Helena, PhD, Touboul, Pia, MD, Hood, Kerenza, Prof, Mullee, Mark, MSc, O'Reilly, Gilly, PhD, Brugman, Curt, MSc, Goossens, Herman, Prof, Verheij, Theo, Prof

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial

    Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial by Little, Paul, Prof, Stuart, Beth, PhD, Francis, Nick, PhD, Douglas, Elaine, MSc, Tonkin-Crine, Sarah, PhD, Anthierens, Sibyl, PhD, Cals, Jochen WL, PhD, Melbye, Hasse, Prof, Santer, Miriam, PhD, Moore, Michael, FRCGP, Coenen, Samuel, Prof, Butler, Chris, Prof, Hood, Kerenza, Prof, Kelly, Mark, PhD, Godycki-Cwirko, Maciek, PhD, Mierzecki, Artur, PhD, Torres, Antoni, Prof, Llor, Carl, PhD, Davies, Melanie, MSc, Mullee, Mark, MSc, O'Reilly, Gilly, PhD, van der Velden, Alike, PhD, Geraghty, Adam WA, PhD, Goossens, Herman, Prof, Verheij, Theo, Prof, Yardley, Lucy, Prof

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial

    Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial by Meininger, Vincent, MD, Genge, Angela, MD, van den Berg, Leonard H, Prof, Robberecht, Wim, Prof, Ludolph, Albert, Prof, Chio, Adriano, Prof, Kim, Seung H, Prof, Leigh, P Nigel, Prof, Kiernan, Matthew C, Prof, Shefner, Jeremy M, Prof, Desnuelle, Claude, Prof, Morrison, Karen E, Prof, Petri, Susanne, Prof, Boswell, Diane, BSc, Temple, Jane, PhD, Mohindra, Rajat, MD, Davies, Matt, MSc, Bullman, Jonathan, BSc, Rees, Paul, PhD, Lavrov, Arseniy, Dr

    Published in Lancet neurology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: